Rifaximin treatment for encephalopathy reduces hospital resource use: real-world data don’t fail to IMPRESS

John D Ryan; Emmanuel A Tsochatzis

doi:10.1136/flgastro-2017-100852

Article Text

Education

Opinion

Rifaximin treatment for encephalopathy reduces hospital resource use: real-world data don’t fail to IMPRESS

https://doi.org/10.1136/flgastro-2017-100852

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

Liver
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

Mark Hudson Amr Radwan Paola Di Maggio Riccardo Cipelli Stephen D Ryder John F Dillon William Jonathan Cash Robert T Przemioslo Mark Wright Debbie L Shawcross Rajiv Jalan Sushma Saksena Michael Allison Paul Richardson Elizabeth Farrington Richard J Aspinall
Frontline Gastroenterology 2017; 8 243-251 Published Online First: 07 Apr 2017. doi: 10.1136/flgastro-2016-100792

Log in using your username and password

Main menu

Log in using your username and password

You are here

Statistics from Altmetric.com

Request Permissions

Footnotes

Linked Articles

Read the full text or download the PDF:

Log in using your username and password

Read the full text or download the PDF:

Log in using your username and password